Priti Ramgarhia

About the Author Priti Ramgarhia

Novavax Extends SK Bioscience Partnership For Supply Of 40M COVID-19 Vaccine Doses

Novavax, a biotechnology company, and SK Group’s vaccine subsidiary extended their collaboration and license agreement for the manufacturing of an additional 40 million …

AstraZeneca Wins WHO Emergency Listing For COVID-19 Vaccine; Street Sees 31% Upside

AstraZeneca announced yesterday that the World Health Organization (WHO) has granted an Emergency Use Listing (EUL) for its COVID-19 vaccine. The authorization permits …

NexTier Posts Better-Than-Feared Quarterly Loss Amid Operational Efficiency

NexTier Oilfield Solutions posted a lower-than-expected loss in the fourth quarter, driven by a rise in activity growth across all product and service …

NextEra Energy Ramps Up Quarterly Dividend By 10%; Street Says Buy

NextEra Energy raised its quarterly common stock dividend by 10% to $0.385 per share.

Wesco Sells Datacom Business In Canada; Street Says Buy

Wesco International on Feb. 12 announced the sale of its Canada Datacom business to Guillevin International, a Canadian distributor of industrial products.

CAE’s Quarterly Profit Lags Estimates Amid Air Travel Slump

CAE’s fiscal third-quarter earnings missed analysts’ expectations impacted by the pandemic-led halt of the travel industry as well as restructuring costs and lower …

Moody’s Posts Better-Than-Expected 4Q Revenue But Profit Disappoints

Moody’s reported better-than-expected 4Q sales driven by currency tailwind. However, higher costs kept earnings under pressure.

Lincoln Electric Posts Better-Than-Expected Quarterly Profit; Street Sees 5% Upside

Lincoln Electric Holdings posted better-than-expected earnings in the fourth quarter, driven by an expansion of adjusted operating margin and prudent cost management. However, …

Coherent Gets $6.5B Buyout Offer From II–VI; Shares Jump 13.8%

Shares of Coherent jumped nearly 13.8% on Feb.

G1 Therapeutics Wins FDA Approval For COSELA Drug; Shares Pop 20%

G1 Therapeutics announced that the US Food and Drug Administration (FDA) has approved its COSELA drug as a first-of-its-kind treatment for patients with …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts